The 8 most recent market catalysts affecting $NNOX, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 10, 2026
Corporate Catalyst
Bullish
Impact 55
Nanox Imaging Announces Distribution Agreement With SOLME To Market And Support Nanox.ARC In Costa Rica
Nanox Imaging announced a distribution agreement with SOLME RC, S.A. to introduce its Nanox.ARC digital tomosynthesis system to Costa Rica. This marks Nanox's third Latin American …
Sep 9, 2026
Corporate Catalyst
Bearish
Impact 95
NANO-X IMAGING shares are trading lower after the company reported worse-than-expected Q2 financial results. The company announced restructuring that includes a 67% workforce reduction.
The headline indicates a major corporate catalyst for NANO-X IMAGING (NNOX). Worse-than-expected financial results combined with a drastic 67% workforce reduction point to severe o…
Sep 9, 2026
Corporate Catalyst
Bearish
Impact 92
Nano X Imaging Q2 Adj. EPS $(0.17) Misses $(0.16) Estimate, Sales $4.156M Miss $5.385M Estimate
Nano X Imaging (NNOX) announced its Q2 earnings, revealing a loss of $(0.17) per share, missing the analyst consensus of $(0.16), and sales of $4.156 million, significantly below t…
Sep 4, 2026
Corporate Catalyst
Bullish
Impact 55
Nano-X Imaging Subsidiary Nanox Impact Enters Into Distribution Agreement With Associated X-Ray Imaging To Support Deployment Of Nanox.ARC Across New England
Nanox, through its subsidiary Nanox Impact, has entered into a distribution agreement with Associated X-Ray Imaging. This partnership is significant as it expands the commercial re…
Aug 18, 2026
Corporate Catalyst
Bullish
Impact 55
Nanox Imaging's Nanox AI Subsidiary Signs Reseller Agreement With Vertec Scientific To Commercialize Nanox.AI Bone Solution In U.K.
Nanox Imaging, through its Nanox AI subsidiary, has entered into a significant reseller agreement with Vertec Scientific for its HealthOST bone solution in the United Kingdom. This…
Aug 11, 2026
Corporate Catalyst
Neutral
Impact 55
Nano-X Imaging CEO And Director Erez Meltzer Buys 9,443 Ordinary Shares At $1.03 Per Share
The filing reveals that Nano-X Imaging's CEO and Director, Erez Meltzer, acquired 9,443 ordinary shares of the company. This insider purchase, while not a massive sum, signals that…
Aug 10, 2026
Corporate Catalyst
Neutral
Impact 55
Nanox AI Optimizes Medical Imaging AI For On-Premise Edge Inference With Intel Core Ultra And OpenVINO
Nanox AI has optimized its medical imaging AI application framework to run efficiently on Intel Core Ultra processors using the OpenVINO toolkit. This is significant because it all…
Aug 6, 2026
Corporate Catalyst
Neutral
Impact 65
Nano-X Imaging Prices Placement Of 8M Shares And Warrants To A Long-Term Institutional Investor At $1.00 Per Unit
Nano-X Imaging announced a private placement of 8 million shares and warrants at $1.00 per unit, raising $8 million. This capital infusion provides the company with much-needed fun…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.